Speed
79 days to first decision for reviewed manuscripts only
75 days to first decision for all manuscripts
120 days from submission to acceptance
19 days from acceptance to publication
Citation Impact
1.096 - Source Normalized Impact per Paper (SNIP)
0.477 - SCImago Journal Rank (SJR)
2.400 - CiteScore
Usage
101,345 Downloads
9 Altmetric Mentions
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Tumor necrosis factor alpha (TNF-?) is an important pro-inflammatory cytokine associated with a variety of ocular diseases. The currently available TNF-? inhibitors are etanercept, infliximab, adalimumab, goli...
Citation: Journal of Ophthalmic Inflammation and Infection 2014 4:26